Mixed Sales Growth

Group sales growth was modest at 1 %, but comparable sales increased 4 %. Order intake fell 1 % in the quarter yet rose 5 % on a rolling 12‑month basis, reflecting sustained commercial momentum. Diagnosis and Treatment sales grew 2.4 %, image‑guided therapy saw high single‑digit growth, Connected Care sales increased 2.2 % with monitoring at mid‑single‑digit growth, and Personal Health sales jumped 8.5 %, led by North America.